Biodiesel is produced by a process called transesterification in which vegetable oils, animal fats, or waste cooking oil are converted into methyl esters through a chemical reaction with methanol in the presence of a catalyst, such as sodium methylate. The conversion process results in pure Biodiesel (B100) being produced as well as glycerine (crude) as a by-product.
Biodiesel performs similarly to mineral diesel with comparable economy, horsepower and combustion and has the following advantages:
Gomedic produces consistent, high quality biodiesel - an alternative diesel engine fuel which, unlike petroleum diesel, is renewable and environmentally friendly.
The global market for biodiesel is growing rapidly as countries work to reduce their greenhouse gas emissions and look to more sustainable energy sources. A valuable commercial by-product of biodiesel manufacture is glycerine. Industrial, and particularly, pharmaceutical grades of glycerine are in high demand. The glycerine market provides Gomedic with an additional revenue stream.
The issue of global warming has initiated schemes - like the Kyoto Protocol - to reduce the amount of greenhouse gases emitted into the atmosphere. Carbon credits , which form part of the Kyoto Protocol, represent a significant future potential revenue stream for Gomedic. |